Preliminary Results of a Prospective Randomized Study of Cyclosporine Versus Tacrolimus in the Development of Cardiac Allograft Vasculopathy at 1 Year After Heart Transplantation

Abstract Introduction and aims Cardiac allograft vasculopathy (CAV) is the leading cause of death after the first year post–heart transplantation (HT). Numerous factors have been implicated in the development of CAV. The aim of this prospective randomized study was to assess the impact of cyclospori...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Transplantation proceedings 2010-10, Vol.42 (8), p.3199-3200
Hauptverfasser:	Sánchez-Lázaro, I.J, Almenar-Bonet, L, Martínez-Dolz, L, Buendía-Fuentes, F, Navarro-Manchón, J, Raso-Raso, R, Agüero, J, Salvador-Sanz, A
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibacterial agents Antibiotics. Antiinfectious agents. Antiparasitic agents Biological and medical sciences Cyclosporine - administration & dosage Cyclosporine - therapeutic use Fundamental and applied biological sciences. Psychology Fundamental immunology Heart Transplantation - adverse effects Humans Immunosuppressive Agents - administration & dosage Immunosuppressive Agents - therapeutic use Medical sciences Pharmacology. Drug treatments Prospective Studies Surgery Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Tacrolimus - administration & dosage Tacrolimus - therapeutic use Tissue, organ and graft immunology Vascular Diseases - etiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!